about
Taurine regulation of blood pressure and vasoactivity.Taurine regulation of short term synaptic plasticity in fragile X miceTaurine Recovery of Learning Deficits Induced by Developmental Pb2+ Exposure.Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions.Effects of taurine on anxiety-like and locomotor behavior of mice.Taurine recovers mice emotional learning and memory disruptions associated with fragile x syndrome in context fear and auditory cued-conditioning.The effects of low dose MK-801 administration on NMDAR dependent executive functions in pigeons.Taurine effects on emotional learning and memory in aged mice: neurochemical alterations and differentiation in auditory cued fear and context conditioning.Assessment of intradimensional/extradimensional attentional set-shifting in rats.The effects of chronic taurine supplementation on motor learning.Changes in gene expression at inhibitory synapses in response to taurine treatment.Perinatal Pb2+ exposure alters the expression of genes related to the neurodevelopmental GABA-shift in postnatal rats.Resurgent lead poisoning and renewed public attention towards environmental social justice issues: A review of current efforts and call to revitalize primary and secondary lead poisoning prevention for pregnant women, lactating mothers, and childrenUltrasonic vocalization sex differences in 5-HT1A-R deficient mouse pups: Predictive phenotypes associated with later-life anxiety-like behaviorsThe attention set-shifting test is sensitive for revealing sex-based impairments in executive functions following developmental lead exposure in ratsAssessing the Anxiolytic Properties of Taurine-Derived Compounds in Rats Following Developmental Lead Exposure: A Neurodevelopmental and Behavioral Pharmacological Pilot StudyEarly Neurodevelopmental Exposure to Low Lead Levels Induces Fronto-executive Dysfunctions That Are Recovered by Taurine Co-treatment in the Rat Attention Set-Shift Test: Implications for Taurine as a Psychopharmacotherapy Against Neurotoxicants
P50
Q34326825-878A1EDB-FE21-469B-9429-360FA1605A75Q34364379-B5DD822A-F445-4213-928E-853C0D274731Q38604348-998F3614-9595-481A-B4E7-F931B21AD4DBQ40226041-9DB4E59E-82F7-4BD6-93F5-B1578FD857AFQ46111202-D22A156E-3ADB-48AA-8D23-83D498291594Q47722672-07177969-ECD9-4F84-85F9-2A9F6882B787Q47991098-321E85F1-C378-4B2D-9167-4A0B2B7F6971Q48170948-0F2C8927-C8C8-4250-8FF3-F6C5292C269AQ50422151-D788C341-8597-4209-9FDC-5C7E90CC4B66Q50760599-8129F47C-8F5C-4ACC-8008-6E5745A4C57DQ50914940-A3C5C8C9-5418-4116-B1E9-FB1EB946CC64Q55136943-60500265-D4DC-4452-B6C7-BDE7CE804C92Q91110928-F875D871-C8F5-4E3B-A2FF-705BB3858636Q91744502-5324DDAF-CF6E-4887-9719-2C019521ADD7Q92410858-E2B0955E-9993-4ADC-BF24-A077B736EA18Q93003477-059B0518-87FA-4D2D-968B-BE30D3825235Q93003483-926713B1-58E9-4646-B2C2-9505016FA81D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lorenz S Neuwirth
@nl
Lorenz S Neuwirth
@sl
Lorenz S. Neuwirth
@en
Lorenz S. Neuwirth
@es
type
label
Lorenz S Neuwirth
@nl
Lorenz S Neuwirth
@sl
Lorenz S. Neuwirth
@en
Lorenz S. Neuwirth
@es
prefLabel
Lorenz S Neuwirth
@nl
Lorenz S Neuwirth
@sl
Lorenz S. Neuwirth
@en
Lorenz S. Neuwirth
@es
P106
P1153
26423874200
P31
P496
0000-0002-8194-522X